Skip to main content
A

ATOMO DIAGNOSTICS LIMITED — Investor Relations & Filings

Ticker · AT1 ISIN · AU0000080327 ASX Manufacturing
Filings indexed 389 across all filing types
Latest filing 2024-03-03 Regulatory Filings
Country AU Australia
Listing ASX AT1

About ATOMO DIAGNOSTICS LIMITED

https://www.atomodiagnostics.com/

Atomo Diagnostics Limited specializes in the design and manufacture of integrated rapid diagnostic test (RDT) platforms. The company focuses on improving the usability and reliability of point-of-care testing through its proprietary AtomoRapid technology. This platform integrates essential components, such as a safety lancet and a calibrated blood collection system, into a single, user-friendly device. Key applications include HIV screening, COVID-19 detection, and pregnancy testing. By simplifying the testing procedure and reducing the risk of user error, the company provides solutions for both professional clinical environments and consumer self-testing markets. Its products are designed to deliver laboratory-grade accuracy in decentralized settings, supporting global health initiatives and individual health management.

Recent filings

Filing Released Lang Actions
Change of Company Secretary 1 page 171.3KB
Regulatory Filings
2024-03-03 English
Appendix 4D and Half Year Report ended 31 Dec 2023 24 pages 890.8KB
Regulatory Filings
2024-02-25 English
H1 FY24 Results Presentation 15 pages 2.0MB
Regulatory Filings
2024-02-25 English
Investor Webinar Presentation 1 page 160.4KB
Regulatory Filings
2024-02-20 English
Appendix 4C - 31 December 2023 5 pages 850.0KB
Regulatory Filings
2024-01-28 English
Quarterly Activity Report - 31 December 2023 6 pages 651.5KB
Regulatory Filings
2024-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.